Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01775
Species: Homo sapiens
Position : chr1:191100000-191150000
Year: 2024
Title: Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: nasopharyngeal carcinoma
PMID:  38490101
MONDO: MONDO:0015459
Tissue: plantar part of pes
Tissue Ontology ID: UBERON:0008338
Cell Source: C666-1
CVCL ID: CVCL_7949
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Enhancer activity assay, Chromatin interaction assay, Functional perturbation assay; TF binding assay; Chromatin interaction assay; Chromatin-state profiling
High Throughput Method: Hi-C, 4C-seq, ChIP-seq, RNA-seq; RNA-seq; ChIP-seq; Hi-C; ChIA-PET; 4C-seq
Low Throughput Method: siRNA Knockdown, RT-RT-qPCR, Western blot, IHC; ChIP; 4C
About Target Gene
Target gene : PLA2G4A
About TF
TF name : REL
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
REL Activation of NF-kappaB in B cells reactome 66
REL Apoptosis signaling pathway panther 104
REL Atypical NF-kappaB pathway pid 14
REL BCR netpath 161
REL IL1 netpath 69
REL Leptin netpath 98
REL RANKL netpath 84
REL Regulation of Androgen receptor activity pid 54
REL TCR netpath 261
REL TNFalpha netpath 274
REL Hs_TNF_alpha_Signaling_Pathway_WP231_89895 wikipathways 61
REL Hs_T-Cell_antigen_Receptor_(TCR)_Signaling_Pathway_WP69_89937 wikipathways 60
REL Hs_IL-1_signaling_pathway_WP195_89932 wikipathways 34
REL Hs_B_Cell_Receptor_Signaling_Pathway_WP23_89900 wikipathways 71
Enhancer Associated Network
Overlapping Enhancers (hg19) 1 found
Enhancer ID Position Tissue Cell Disease
E_01776 chr1:191100000-191150000 plantar part of pes malignant cell nasopharyngeal carcinoma
Expression of Target Genes for the Enhancer